Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia
David A. Martin(National Institutes of Health), Michael J. Lenardo(National Institutes of Health), Richard M. Siegel(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Marcus E. Peter(Northwestern University), Jin Wang(Nanjing University of Chinese Medicine), Peter H. Krammer(Slovak Academy of Sciences), Galen H. Fisher(National Institutes of Health), Lixin Zheng(Massachusetts Eye and Ear Infirmary), Christine E. Jackson(National Institutes of Health), Baohua Huang(National Institutes of Health), Stephen E. Straus(Toronto Public Health), Stephen W. Fesik(Vanderbilt University), Janet K. Dale(National Institutes of Health), Jennifer M. Puck(University of California, San Francisco)
Cited by 181
Related Papers
A guide to cancer immunotherapy: from T cell basic science to clinical practice
|Nature reviews. Immunology|2020|4.1k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k